Targeting the Endocannabinoid System to Reduce Inflammatory Pain
The endogenous cannabinoids (endocannabinoids) anandamide (AEA) and 2-arachidonylglycerol (2-AG) exert their effects predominantly through cannabinoid CB1 and CB2 receptors, but these actions are short-lived because of rapid hydrolysis by fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase...
Main Author: | Ghosh, Sudeshna |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2012
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/313 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1312&context=etd |
Similar Items
-
The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation
by: Ahmet Ulugöl
Published: (2014-06-01) -
Differential roles of the two major endocannabinoid hydrolyzing enzymes in cannabinoid receptor tolerance and somatic withdrawal
by: Schlosburg, Joel
Published: (2010) -
A Guide to Targeting the Endocannabinoid System in Drug Design
by: Adam Stasiulewicz, et al.
Published: (2020-04-01) -
LOS ENDOCANABINOIDES: UNA OPCIÓN TERAPÉUTICA PARA EL TRATAMIENTO DEL CÁNCER ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
by: Fabio MAYORGA N, et al.
Published: (2009-05-01) -
Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
by: Marialessandra Contino, et al.
Published: (2020-03-01)